HCV Education
Listen to experts discuss important HCV related topics in the following easy to access webinar programs presented by HepCure.
Listen
On Tuesday, October 9th, Susan Lee, PharmD BCPS CDE of Northwell Health, presented on:
Hepatitis C Prior Authorization: Tricks of the TradeTopics
1. Discuss tests needed to apply for Hepatitis C (HCV) therapy prior authorization.
2. Identify essential resources for patients approved for treatment.
3. Describe options for patients denied HCV therapy
Begin here.....
SAVE THE DATE
October 23, 2018
UPCOMING: Hepatitis C Anti-Viral Therapy Guidance Review 2018
In The News
HepCBC is a non-profit organization run by and for people infected and affected by viral hepatitis. Our mission is to provide education, prevention and support to those living with viral hepatitis.
Weekly Review: read the latest issue of the Weekly Bull.
MedPage Today
AGA Reading Room
10.18.2018
Hep C Rates High Among People with Mental Health Disorders
With the advent of direct-acting antiviral (DAA) therapy, the possibility of eradicating hepatitis C virus (HCV) is real; however, HCV treatment needs to be broadly available and utilized. The prevalence of HCV is likely high among individuals with mental health disorders who may also suffer from substance use disorders. Partnerships between mental health providers and clinicians treating HCV could potentially increase access to DAA therapy and improve overall care. If underlying mental health disorders are not addressed, the risks of nonadherence to DAA therapy or re-infection with HCV are greater. Additionally, mental health providers should recognize the increased risk for HCV in their patient population and have the tools needed to link them to care. More research is needed to understand the optimal care delivery approaches for patients with both mental health disorders and HCV.
Begin here.....
Top Story From Healio
Healio features the industry’s best news reporting, dynamic multimedia, question-and-answer columns, educational activities in a variety of formats, blogs, and peer-reviewed journals.
October 20, 2018 This year at the American College of Gastroenterology Annual Meeting, several hepatology specialists discussed the changing landscape of liver disease health care, such as increasing rates of nonalcoholic fatty liver disease which is quickly becoming the number one indication for liver transplantation. Healio presents the following liver disease highlights from ACG 2018 including an improved liver biopsy attenuation technique, the risks and course of NAFLD depending on patient demographics, and liver disease in pregnant patients.
On Twitter - @HenryEChang
Hepatitis C Virus Improving #hepatitis C direct-acting antiviral access & uptake: a role for patient-reported outcomes & lived-experience→https://jmp.sh/Ejs7cuS
Hepatitis B Virus On-treatment improvement of MELD score reduces death & hepatic events in patients with #hepatitis B-related #cirrhosis→https://jmp.sh/cCxYoaD
Enjoy the weekend.
Tina
No comments:
Post a Comment